Related Experiment Video
Updated: Jun 25, 2026

Cell Subtype-specific Analysis of Neuronal Membrane Proteasome in Somatosensory Neurons
Published on: October 10, 2025
Bortezomib-induced histiocytoid Sweet syndrome
Jenny E Murase1, Jashin J Wu, Ivan Theate
1Department of Dermatology, University of California, San Francisco, California, USA. jemurase@gmail.com
Abstract:
Bortezomib, a proteasome inhibitor approved for the treatment of multiple myeloma, has been reported to be associated with Sweet syndrome. However, careful review of the histopathology of the first reported case and our case revealed similar histologic and immunohistochemical findings (a mononuclear dermal infiltrate) and not the usual neutrophilic infiltrate of Sweet syndrome. We suggest that the dermatitis induced by bortezomib is best classified as "histiocytoid Sweet syndrome."
Related Concept Videos
Hypersensitivity Reactions: Cytolytic Reactions
Cytotoxic Edema: Pathophysiology
Hyperosmolar Hyperglycemic State
Cytotoxic T Cells-mediated Immune Response
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists
Rous Sarcoma Virus (RSV) and Cancer
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
